The European Medicines Agency Review of Decitabine (Dacogen) for the Treatment of Adult Patients With Acute Myeloid Leukemia: Summary of the Scientific Assessment of the Committee for Medicinal Products for Human Use

On September 20, 2012, a marketing authorization valid throughout the European Union (EU) was issued for decitabine for the treatment of adult patients aged 65 years and older with newly diagnosed de novo or secondary acute myeloid leukemia (AML) who are not candidates for standard induction chemoth...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncologist
Main Authors: Nieto, Maria, Demolis, Pierre, Béhanzin, Eliane, Moreau, Alexandre, Hudson, Ian, Flores, Beatriz, Stemplewski, Henry, Salmonson, Tomas, Gisselbrecht, Christian, Bowen, David, Pignatti, Francesco
Formato: Artigo
Idioma:Inglês
Publicado em: AlphaMed Press 2016
Assuntos:
Regulatory Issues: EMA
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4912358/
https://ncbi.nlm.nih.gov/pubmed/27091416
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2015-0298
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados